vectura
Vectura removed from DDL Conference amid PMI deal
September 21, 2021Manufacturing and Production DDL, inhalers, pmi, vectura
Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to …
Vectura CEO to step down at end of June
June 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, vectura
Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO …
Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling
November 27, 2018Manufacturing and Production, Research and Development asthma, pharma, trial failure, vectura
Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, …
Vectura’s COO set to step down
March 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura
Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
Vectura asthma treatment fails at Phase III
August 30, 2016Manufacturing and Production, Research and Development asthma, inhaler, phase III, phase III failure, vectura
Respiratory drug specialist Vectura’s asthma treatment Flutiform was unsuccessful in meeting the primary endpoint in its Phase III trial conducted …
Vectura agree £441m merger with Skyepharma
March 16, 2016Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura
Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …
J&J acquires Index Ventures-owned firm XO1
March 23, 2015Sales and Marketing Index Ventures, Isis, J&J, JJ, Janssen, vectura, xo1
Johnson & Johnson’s pharma unit Janssen has acquired Index Ventures’ biopharma firm XO1 Limited that develops the promising anti-thrombin antibody …
Vectura and J&J shake on asthma/COPD deal
January 6, 2015Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura
British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …
GSK breathes more easily after Sandoz exit
March 24, 2010Sales and Marketing Advair, Sandoz, generics, vectura
Sandoz has exited a deal to launch a generic rival to GSK’s top selling respiratory drug Advair. Sandoz, the generics …
Vectura buys Innovata
January 22, 2007Research and Development biotech, vectura
Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …
Latest content
FibroFind appoints Lee Borthwick as CEO
